Alteryx (NYSE: AYX) had the rare combination of high growth and profitability heading into FY2020, thanks to best of breed software offerings and strong sales execution. The company has held significant pricing power, which they've so far exercised liberally, without having to sacrifice growth.
However, with the pandemic uncertainty, management expects headwinds and issued weak Q2 guidance. A significant hit to growth is expected, even after accounting for the usual outperformance on consensus estimates.
Alteryx may be a future winner, but I don’t see enough upside at the current valuation (NTM EV/S of 16.3x)